Lv1
41 积分 2024-08-05 加入
The changing therapeutic landscape of castration-resistant prostate cancer
1天前
待确认
Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
5天前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
6天前
已完结
不同方案治疗转移性激素敏感性前列腺癌有效性和安全性Meta分析
7天前
已完结
高危前列腺癌术后辅助放射治疗的研究进展
14天前
已完结
Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance
19天前
已完结
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity
19天前
已完结
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review
19天前
已完结
A controlled trial of Casodex (bicalutamide) vs. flutamide, each in combination with luteinising hormone-releasing hormone analogue therapy in patients with advanced prostate cancer. Casodex Combination Study Group
22天前
已完结
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group
22天前
已完结
皖公网安备34019202002308
